Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Le Kremlin-Bicêtre
Clinical trial register · France

Clinical Trials in Le Kremlin-Bicêtre, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 13 Lille 10 Le Kremlin-Bicêtre 8 Bron 7 Toulouse 6
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris49 Novartis Pharmaceuticals9 Novo Nordisk A/S8 Eli Lilly and Company7 Hoffmann-La Roche6 Clear sponsor filter
Site location
Paris13 Lille10 Le Kremlin-Bicêtre8 Bron7 Toulouse6
All 53 locations
Target enrolment
to

Trials with a site in Le Kremlin-Bicêtre

8 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Novo Nordisk A/S
Phase 3
84
Bron, Le Kremlin-Bicêtre, Lille, Nantes
2026-10-09
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Bron, Le Kremlin-Bicêtre, Lille, Nantes
2023-02-13
Active, closed
Novo Nordisk A/S
Phase 3
412
Angers, Bordeaux, Le Kremlin-Bicêtre, Marseille, Marseille Cédex 05, Paris, Toulouse
2022-08-10
Active, closed
Novo Nordisk A/S
Phase 3
153
Chambéry, Le Kremlin-Bicêtre, Paris
2022-03-24
By invitation
Novo Nordisk A/S
Observational
221
Angers, Le Kremlin-Bicêtre, Toulouse
2022-03-16
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Brest, Caen, Le Kremlin-Bicêtre, Nantes, Rennes, Saint-Priest-en-Jarez
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Bron, Clermont-Ferrand, Le Kremlin-Bicêtre, Rennes
2019-10-21
Active, closed
Novo Nordisk A/S
Phase 2
62
Angers, Le Kremlin-Bicêtre, Marseille, Marseille Cédex 05, Paris, Toulouse
2019-07-04
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-france/city/le-kremlin-bic-tre

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Le Kremlin-Bicêtre that also match the filters currently applied.

How many clinical trials are recruiting in Le Kremlin-Bicêtre?

0 of the 8 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 1 have not yet opened recruitment, 6 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Le Kremlin-Bicêtre), 8 studies
PhaseStudiesRecruitingShare
Phase 36075%
Observational1012.5%
Phase 21012.5%

Most active sponsors

Lead sponsors with the most studies (Le Kremlin-Bicêtre)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S80
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.